Keywords: Roche, Tarceva, NSCLC, UK, NICE

UK’s NICE sticks with negative view on Roche’s Tarceva for NSCLC

Article | 29 June 2011

Print This

Having previously issued negative opinions on the cancer drug, this morning the UK’s National Institute for Health and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in